Date: June 19 - 22, 2017
Location: San Diego, CA
The BIO International Convention (BIO) attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. This event covers a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
Date: June, 20, 2017
Time: 1:20pm - 2:00pm
Location: BioProcess Theater
Title: Bio-CMOs: How Their Business Models Have Adapted to Meet the Challenges and Opportunities of the Protein-Based and Emerging Therapy Markets
Panelists Representing: Ajinomoto Althea, Catalent Biologics, Cook Pharmica, Pfizer CentreOne
While the development and manufacture of emerging therapies follow a similar process as protein-based therapies, there are many unique equipment, technology, logistic, and scientific challenges that must be addressed early in the process to ensure greater chance for commercial success. As CMOs have enhanced their experience and capabilities in this niche, outsourcing development and manufacturing has now become a viable option for many companies.